CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia
Status:
Recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
In this study, CAR-T will be administered to children with acute lymphoblastic leukemia to
explore the effect of CAR-T intervention time on the duration of complete remission and
further verify the long-term safety and efficacy of CAR-T treatment.